Invoxia pushes dog wearables deeper into veterinary care

Invoxia is making a clearer push into veterinary care, not just consumer pet tech. In episode 316 of the Veterinary Innovation Podcast, released April 2, 2026, Eric Humbert, Invoxia’s head of science and AI, described how the company’s Biotracker wearable and Biotrack veterinary platform are designed to give clinics access to continuous, at-home cardiorespiratory and activity data between visits. The company has also tied that pitch to emerging published evidence: a 2025 Frontiers in Veterinary Science study using Invoxia device data from 703 dogs aimed to build long-term resting heart rate and respiratory rate reference data in home environments, while Invoxia says the platform can support post-op follow-up, chronic disease monitoring, and preventive care. (podcasts.apple.com)

Why it matters: For veterinary professionals, the story isn’t just another wearable. It’s part of a broader effort to make remote monitoring operational inside practice workflows, with dashboards, trend alerts, and clinic-branded monitoring plans. That aligns with AAHA/AVMA telehealth guidance, which says practices should decide in advance how wearable data will be received and used as part of a wellness or treatment plan. The opportunity is better longitudinal context and earlier intervention; the challenge is deciding which data are clinically meaningful, how teams will review them, and how monitoring is billed and integrated into care. (invoxia.com)

What to watch: Watch for whether Invoxia can translate early validation studies and product claims into broader clinical adoption, workflow integration, and independent evidence tied to outcomes. (frontiersin.org)